Concepedia
Statistics
Publications
20
Citations
679
H-Index
15
Active since
2008
Affiliations
Texas Tech University(Current)
Texas Tech University Health Sciences Center
University of Milan
The University of Texas MD Anderson Cancer Center
Lubbock Christian University
Leonardo Mirandola is an author at Texas Tech University specializing in oncology, medicine, and cancer immunotherapy.
Publications per year
2008–2019
Anti-Notch treatment prevents multiple myeloma cells localization to the bone marrow via the chemokine system CXCR4/SDF-1
Leonardo Mirandola, L. Apicella, M. Colombo et al. · Leukemia · 2013 · 82 citations
Medicine, Cell Biology, Oncology +14
Galectin-3C Inhibits Tumor Growth and Increases the Anticancer Activity of Bortezomib in a Murine Model of Human Multiple Myeloma
Leonardo Mirandola, Yuefei Yu, Kitty Chui et al. · PLoS ONE · 2011 · 66 citations · Full text
Medicine, Oncology, Pharmacology +17
Notch1 regulates chemotaxis and proliferation by controlling the CC‐chemokine receptors 5 and 9 in T cell acute lymphoblastic leukaemia
Leonardo Mirandola, Maurizio Chiriva‐Internati, Daniela Montagna et al. · The Journal of Pathology · 2011 · 63 citations
Life Sciences, Cell Biology, Oncology +17
Identification of AKAP‐4 as a new cancer/testis antigen for detection and immunotherapy of prostate cancer
Maurizio Chiriva‐Internati, Yuefei Yu, Leonardo Mirandola et al. · The Prostate · 2011 · 53 citations
Medicine, Immunology, Oncology +17
Cancer Testis Antigen Vaccination Affords Long-Term Protection in a Murine Model of Ovarian Cancer
Maurizio Chiriva‐Internati, Yuefei Yu, Leonardo Mirandola et al. · PLoS ONE · 2010 · 51 citations · Full text
1–5 of 20